Background And Objective: To describe and present the reliability and reproducibility of a new software, Retinal Volume Analyzer (ReVAnalyzer), for pigment epithelium detachment (PED) volume quantification.
Patients And Methods: This is a retrospective study including patients with PEDs secondary to exudative age-related macular degeneration (AMD). Macular volume scans on spectral-domain optical coherence tomography on enhanced depth imaging mode were performed in all eyes. Image batches were then exported in .xml format to the ReVAnalyzer software. A semiautomated PED volume measurement was performed by three independent readers (RBG, VC, OS) twice, at the beginning and end of a 15-day period. Bland-Altman assessment for agreement was used to compare intra- and interobserver observations.
Results: Twenty eyes of 20 patients presenting with PED were analyzed. Bland-Altman analysis indicated a good agreement between inter- and intraobserver measurements. The intraclass correlation coefficient for intraobserver PED volume measurements and between the three observers (interobserver) was greater than 0.99, demonstrating high reproducibility and consistency of the methodology.
Conclusions: ReVAnalyzer is a reliable tool that can assist in the analysis of PED volume with high reproducibility. This type of specific retinal volume analysis can be of help for monitoring disease activity and therapeutic response in AMD. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:e242-e249.].
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3928/23258160-20190905-16 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Changes in Behavioral Health Visits, Operations, and Boarding in a Pediatric Emergency Department.
Ann Emerg Med
November 2024
Department of Emergency Medicine, Harvard Medical School, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA; Division of Emergency Medicine, Boston Children's Hospital, Boston, MA.
Study Objective: Over the past decade, there has been a dramatic increase in pediatric emergency department (PED) visits seeking mental and behavioral health care. We aimed to determine the relationship between hours of care devoted to patients with mental and behavioral health complaints and markers of PED throughput and timeliness.
Methods: We performed a retrospective, single-center, cross-sectional study of PED encounters between 2010 and 2022.
Correlation of retinal fluid and photoreceptor and RPE loss in neovascular AMD by automated quantification, a real-world FRB! analysis.
Acta Ophthalmol
November 2024
Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Purpose: To quantify ellipsoid zone (EZ) loss during anti-VEGF therapy for neovascular age-related macular degeneration (nAMD) and correlate these findings with nAMD disease activity using artificial intelligence-based algorithms.
Methods: Spectral domain optical coherence tomography (Spectralis, Heidelberg Engineering) images from nAMD treatment-naïve patients from the Fight Retinal Blindness! (FRB!) Registry from Zürich, Switzerland were processed at baseline and over 3 years of follow-up. An approved deep learning algorithm (Fluid Monitor, RetInSight) was used to automatically quantify intraretinal fluid (IRF), subretinal fluid (SRF) and pigment epithelial detachment (PED).
Pediatric Trauma Management in Switzerland: Insights from a Nationwide Survey.
Clin Exp Emerg Med
October 2024
Emergency Department, University's Children Hospital Zurich, University of Zurich, Zurich, Switzerland.
Objective: To explore and analyze pediatric trauma care practices across designated pediatric trauma centers (PTCs) in Switzerland. The focus is on reception, trauma team activation (TTA), trauma team composition, patient volumes, and infrastructure.
Methods: A national online survey was conducted among all eight PTCs in Switzerland with an 18- item questionnaire.
Artificial intelligence-based analysis of retinal fluid volume dynamics in neovascular age-related macular degeneration and association with vision and atrophy.
Eye (Lond)
October 2024
F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Article Synopsis
- The study focuses on evaluating the morphological changes in neovascular age-related macular degeneration (nAMD) during anti-angiogenic therapy and how these changes relate to visual acuity and the risk of developing macular atrophy (MA).
- It utilized data from the HARBOR trial, analyzing SD-OCT scans from 1097 nAMD eyes to assess the impact of different treatment regimens and MNV subtypes on various retinal fluid volumes.
- The findings indicate that higher initial volumes of intraretinal cystoid fluid and pigment epithelial detachment increase the likelihood of developing MA, while residual fluid volumes are linked to poorer visual outcomes over 24 months.
Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study.
Int J Retina Vitreous
September 2024
Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale (EOC), Via Pietro Capelli 1, Lugano, 6962, Switzerland.
Background: Intravitreal faricimab, a bispecific antibody targeting both angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A), was recently introduced for the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular oedema and cystoid macular oedema secondary to retinal vein occlusion. The aim of our study was to assess the efficacy, safety and durability of intravitreal faricimab in a real-world cohort of treatment-naïve patients with nAMD.
Methods: Single-centre, prospective cohort study of 21 eyes from 19 treatment-naïve nAMD patients who were treated with intravitreal faricimab from October 2022 to April 2024.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!